| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |